Trials / Unknown
UnknownNCT04484922
Dexmedetomidine Neuroprotection in Pediatric Cardiac Surgery
The Effect of Dexmedetomidine on Neuroprotection in Pediatric Cardiac Surgery Patients: a Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
Neurodevelopmental disability is the most significant complication for survivors of infant surgery for congenital heart disease. In this study we sought to determine if intraoperative continuous infusion of dexmedetomidine are associated with neurodevelopmental outcomes at 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | continuous infusion of dexmedetomidine during the surgery |
| DRUG | Normal saline | continuous infusion of normal saline during the surgery |
Timeline
- Start date
- 2020-08-25
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
- First posted
- 2020-07-24
- Last updated
- 2022-02-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04484922. Inclusion in this directory is not an endorsement.